02293.HK
Bamboos Health Care Holdings Limited
HKSE · Healthcare · Medical - Care Facilities · HK
HKD 0.41
−4.71%Income statement
| Metric | TTM | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 141.4M | 66.7M | 74.4M | 94.8M | 126.6M |
| Cost of Revenue | 80.4M | 37.1M | 43.4M | 10.1M | 50.2M |
| Gross Profit | 61.0M | 29.6M | 31.0M | 84.7M | 115.1M |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | 11.3M | 1.2M | 9.5M | 4.4M | 5.3M |
| General & Admin Expense | (2.0K) | 113.0K | — | 4.0M | 4.9M |
| Selling & Marketing Expense | 1.1M | 1.1M | — | 337.0K | 408.0K |
| Other Expenses | 19.9M | 17.4M | (463.0K) | 3.8M | 49.9M |
| Total Operating Expenses | 31.2M | 18.6M | 9.0M | 8.1M | 55.3M |
| Cost and Expenses | 111.7M | 55.7M | 52.4M | 54.1M | 68.0M |
| Operating Income (EBIT) | 29.8M | 11.0M | 22.0M | 40.7M | 59.9M |
| Non-Operating | |||||
| Interest Income | 2.0M | — | 1.6M | 1.3M | 777.0K |
| Interest Expense | 4.2M | — | 3.3M | 3.4M | 2.4M |
| Net Interest Income | (3.1M) | (1.5M) | (1.7M) | (2.1M) | (1.6M) |
| Other Non-Op Income/Expense | 2.1M | (1.5M) | 461.0K | (1.5M) | (1.2M) |
| Non-Operating Income (excl Interest) | (7.3M) | (2.2M) | (3.8M) | (759.0K) | (11.0K) |
| EBT (Pre-Tax Income) | 31.9M | 9.4M | 22.4M | 39.2M | 58.7M |
| Income Tax Expense | 8.1M | 3.2M | 4.9M | 8.3M | 11.8M |
| Bottom Line | |||||
| Net Income | 23.8M | 6.2M | 17.5M | 30.9M | 46.9M |
| Earnings from Cont. Ops | 23.8M | 6.2M | 17.5M | 30.9M | 46.9M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 23.8M | 6.2M | 17.5M | 30.9M | 46.9M |
| Per Share | |||||
| Basic EPS | HK$0.06 | HK$0.02 | HK$0.04 | HK$0.08 | HK$0.12 |
| Diluted EPS | HK$0.06 | HK$0.02 | HK$0.04 | HK$0.08 | HK$0.12 |
| Revenue Per Share | HK$0.35 | HK$0.17 | HK$0.19 | HK$0.24 | HK$0.32 |
| Shares | |||||
| Basic Shares Outstanding | 399.3M | 400.8M | 400.3M | 400.0M | 400.0M |
| Diluted Shares Outstanding | 400.9M | 401.7M | 401.0M | 400.1M | 400.0M |
| Profitability Metrics | |||||
| EBITDA | 51.9M | 15.3M | 35.0M | 52.8M | 69.8M |
| D&A | 14.8M | 2.1M | 9.3M | 10.1M | 10.0M |
| EBIT | 37.1M | 13.2M | 25.7M | 42.6M | 59.9M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026